"The new guidelines are essential reading for anyone interested in
cybersecurity, and how the use of well-established standards-based
authentication procedures help protect the secure access and exchange of
information on the Internet," says Mollie Shields-Uehling, president and
CEO, SAFE-BioPharma Association. "The animated video presents the same
concepts for a general audience."

The global SAFE-BioPharma® standard assures trust in compliant
cyber-identity credentials, which are closely bound to the proven
identity of each individual using the credential. These credentials are
trusted to represent their users among a broad network of government,
corporate and other entities, including all U.S. federal agencies and
the European Medicines Agency. Digital signatures applied using these
credentials are used for regulatory submissions to the FDA and European
Medicines Agency, and are required by the U.S. DEA for electronically
signing prescriptions for controlled substances.

Among the many advantages of identity credentials compliant with the
SAFE-BioPharma standard is the substitution of a single cyber-credential
for the outdated multitude of less secure user name and password
combinations.

"These credentials are like a single passport to the Internet. One
credential is trusted to represent one person across many diverse and
far-reaching boundaries," explains Shields-Uehling.

About SAFE-BioPharma

More information on the SAFE-BioPharma® standard for digital identity
and digital signatures used in life science and health care settings on
the SAFE-BioPharma
website.

SAFE-BioPharma® is a trademark of SAFE-BioPharma Association. Use of
this trademark requires approval from SAFE-BioPharma Association.

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her
physician.